Controversies in reproductive genetics

Precongress Course 4

SIG Ethics and Law SIG Reproductive Genetics Special Interest Groups Ethics and Law and Reproductive Genetics

Course coordinators

Heidi Mertes (Belgium), Theofano Bounartzi (Spain), Lucy Frith (United Kingdom), Margarida Silvestre (Portugal), Nicola Williams (United Kingdom)


Course type


Course description

This course will bring together scientists and ethicists in reproductive medicine to discuss the promise, limitations and ethical concerns connected to several contentious innovations in reproductive genetics. Specific topics to be discussed will be PGT for polygenic risk scores, mitochondrial replacement therapies, uterine lavage for PGT on in vivo produced embryos and genome editing in the human embryo.


Target audience

Reproductive geneticists, ethicists, policy makers, basic scientists in reproductive medicine, clinicians in reproductive medicine, genetic counsellors

Educational needs and expected outcomes

After the course, participants are expected to:

  • be able to formulate a balanced view on innovative and future treatments in reproductive genetics
  • be able to debate better about innovation in medically assisted reproduction engendering societal concerns, based on sound evidence and sound ethical reasoning



Monday 04 July 2022

09:00 - 09:30
PGT for polygenic risk scores: the promise
Nathan Treff, U.S.A.
09:30 - 09:45
09:45 - 10:15
PGT for polygenic risk scores: the limitations and ethical concerns
Cecile Janssens, U.S.A.
10:15 - 10:30
10:30 - 11:00
Coffee break
11:00 - 11:30
Mitochondrial replacement therapies: the promise
Mary Herbert, United Kingdom
11:30 - 11:45
11:45 - 12:15
Mitochondrial replacement therapies: limitations and ethical concerns
Ainsley Newson, United Kingdom
12:15 - 12:30
12:30 - 13:30
Lunch break
13:30 - 14:00
Uterine lavage of in vivo produced eggs and embryos: the promise
Santiago Munne, Spain
14:00 - 14:15
14:15 - 14:45
Uterine lavage for PGT on in vivo produced embryos: the ethical concerns
Guido Pennings, Belgium
14:45 - 15:00
15:00 - 15:30
Coffee break
15:30 - 16:00
Genome editing in the human embryo: the promise
Anna Veiga, Spain
16:00 - 16:15
16:15 - 16:45
Genome editing in the human embryo: the ethical concerns
Sarah Chan, United Kingdom
16:45 - 17:00